AssetMark’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52 Buy
+3
New +$50 ﹤0.01% 3718

Other funds holding JANX

AssetMark's JANX Position: Q3 2026 in Review

AssetMark opened a new position in Janux Therapeutics (JANX) in Q3 2026: 3 shares worth $52. The stake represents ﹤0.01% of the portfolio and ranks #3718 among its holdings.

139 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • AssetMark held 3 shares of Janux Therapeutics worth $52 as of Q3 2026.
  • Janux Therapeutics was a new AssetMark position in Q3 2026.
  • Janux Therapeutics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3718 holding.
  • 139 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.